Disclaimer

The material provided in this web site is for the informational purposes only. The information provided here is incomplete and may be changed. For further information, you should review Nymox's statements filed with the Securities and Exchange Commission in the United States of America and with the Quebec Securities Commission.

You should also be aware that the material posted on this web site contains forward-looking statements as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Factors that could cause such differences are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.

You should not consider or treat the posting of this material as in any way an offer to sell any shares of Nymox Pharmaceutical Corporation or a solicitation of an offer to buy any such shares.

Investing in the shares of Nymox involves a high degree of risk. You should refer to the Risk Factors outlined from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.

Neither the Securities and Exchange Commission, the Quebec Securities Commisson or any state securities commission has approved or disapproved the material posted here or made any findings as to its truthfulness or accuracy. Any representation to the contrary is a criminal offense.